TITAN PHARMACEUTICALS INC Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q2 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Titan Pharmaceuticals Inc quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q2 2024.
  • Titan Pharmaceuticals Inc Entity Common Stock, Shares Outstanding for the quarter ending August 9, 2024 was 914K shares, a 93.9% decline year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 914K -14.1M -93.9% Aug 9, 2024 10-Q 2024-08-15
Q1 2024 914K -14.1M -93.9% Mar 25, 2024 10-K 2024-04-01
Q3 2023 15M +387K +2.65% Nov 10, 2023 10-Q 2023-11-14
Q2 2023 15M +387K +2.65% Aug 9, 2023 10-Q 2023-08-14
Q1 2023 15M +2.98M +24.7% Mar 24, 2023 10-K 2023-03-31
Q3 2022 14.6M +4.72M +47.6% Nov 9, 2022 10-Q 2022-11-14
Q2 2022 14.6M +4.77M +48.3% Aug 8, 2022 10-Q 2022-08-11
Q1 2022 12M +2.18M +22.1% Mar 23, 2022 10-K 2022-03-25
Q3 2021 9.91M -187M -95% Nov 9, 2021 10-Q 2021-11-15
Q2 2021 9.86M -87.4M -89.9% Aug 11, 2021 10-Q 2021-08-16
Q1 2021 9.86M -83.6M -89.4% Mar 26, 2021 10-K 2021-03-31
Q3 2020 197M +141M +254% Nov 10, 2020 10-Q 2020-11-16
Q2 2020 97.2M +81.5M +518% Aug 10, 2020 10-Q 2020-08-14
Q1 2020 93.5M +80.1M +597% Mar 25, 2020 10-K 2020-03-30
Q3 2019 55.5M -22.4M -28.8% Nov 11, 2019 10-Q 2019-11-14
Q2 2019 15.7M -5.46M -25.8% Aug 10, 2019 10-Q 2019-08-14
Q1 2019 13.4M -7.79M -36.7% Mar 25, 2019 10-K/A 2019-04-02
Q3 2018 78M +56.8M +268% Nov 9, 2018 10-Q 2018-11-14
Q2 2018 21.2M 0 0% Aug 10, 2018 10-Q 2018-08-14
Q1 2018 21.2M +4.87K +0.02% Mar 23, 2018 10-K 2018-04-02
Q3 2017 21.2M +4.87K +0.02% Nov 3, 2017 10-Q 2017-11-09
Q2 2017 21.2M +4.87K +0.02% Aug 4, 2017 10-Q 2017-08-09
Q1 2017 21.2M +1.14M +5.68% Mar 10, 2017 10-K 2017-03-16
Q3 2016 21.2M +1.14M +5.68% Nov 4, 2016 10-Q 2016-11-09
Q2 2016 21.2M -89.1M -80.8% Aug 5, 2016 10-Q 2016-08-09
Q1 2016 20.1M -90.3M -81.8% Mar 10, 2016 10-K 2016-03-15
Q3 2015 20.1M -89.9M -81.8% Nov 10, 2015 10-Q 2015-11-16
Q2 2015 110M +21.3M +24% Aug 7, 2015 10-Q 2015-08-13
Q1 2015 110M +21.3M +23.9% Mar 24, 2015 10-K 2015-03-31
Q3 2014 110M +27.5M +33.3% Nov 7, 2014 10-Q 2014-11-13
Q2 2014 89M +6.45M +7.82% Aug 8, 2014 10-Q 2014-08-13
Q1 2014 89.1M +7.24M +8.85% Mar 24, 2014 10-K 2014-03-31
Q3 2013 82.5M +7.33M +9.74% Nov 8, 2013 10-Q 2013-11-14
Q2 2013 82.5M +16.5M +25% Aug 9, 2013 10-Q 2013-08-14
Q1 2013 81.8M +22.4M +37.8% Mar 11, 2013 10-K 2013-03-18
Q3 2012 75.2M +15.8M +26.7% Nov 2, 2012 10-Q 2012-11-09
Q2 2012 66.1M +6.67M +11.2% Aug 6, 2012 10-Q 2012-08-09
Q1 2012 59.4M Mar 9, 2012 10-K 2012-03-15
Q3 2011 59.4M Nov 8, 2011 10-Q 2011-11-14
Q2 2011 59.4M Aug 11, 2011 10-Q/A 2011-08-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.